Vebreltinib for Advanced Non–Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study Devimistat in combination with mFFX did not improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback